FIELD: medicine.
SUBSTANCE: invention refers to medicine and aims at treating diseases associated with Helicobacter pylori. Agent contains resveratrol, sulforophane, broccoli extract, dihydroquercetin and essential phospholipids in ratio per 1,000 mg: resveratrol – 25–600, sulforophane – 0.31–62.5, dihydroquercetin – 5–50, essential phospholipids – 37.5–657.5, broccoli extract – 312.5–250 mg.
EFFECT: invention widens the range of therapeutic agents.
1 cl, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| HORMONAL DISORDERS CORRECTION DEVICE OF REPRODUCTIVE SYSTEM ORGANS | 2019 |
|
RU2712128C1 |
| AGENT FOR CORRECTING MENSTRUAL IRREGULARITIES, MENOPAUSAL DISORDERS | 2022 |
|
RU2801514C1 |
| AGENT FOR CORRECTING DYSPEPTIC DISORDERS OF THE GASTROINTESTINAL TRACT | 2020 |
|
RU2755707C1 |
| METHOD OF TREATING PATIENTS WITH INTESTINAL DISBACTERIOSIS | 2014 |
|
RU2571495C1 |
| METHOD OF TREATING PATIENTS WITH INTESTINAL DYSBACTERIOSIS | 2009 |
|
RU2400235C1 |
| METHOD FOR ANTI-HELICOBACTER THERAPY OF STOMACH AND DUODENUM | 2013 |
|
RU2537140C1 |
| METHOD OF TREATING CHRONIC GASTRODUODENITIS ASSOCIATED WITH INFECTION CAUSED BY BACTERIA Helicobacter pylori IN ALLERGIC DISEASES | 2011 |
|
RU2472498C1 |
| METHOD FOR TREATMENT OF STOMACH AND DUODENUM ULCEROUS DISEASE | 2006 |
|
RU2294204C1 |
| PHARMACEUTICAL COMPOSITION BASED ON HEPATOPROTECTOR AND PREBIOTIC AND METHOD FOR PRODUCING AND APPLYING THE COMPOSITION | 2006 |
|
RU2318538C1 |
| METHOD OF ERADICATION THERAPY SELECTION FOR ULCER PATIENTS ASSOCIATED WITH Helicobacter pylori | 2006 |
|
RU2325164C1 |
